Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-12-15 Kalowski Lee Chief Financial Officer Grant or award · Stock Option (right to buy) +62,000 62,000
2015-09-08 Kalowski Lee Chief Financial Officer Sale −4,668 $13.13 $61K 40,953
2015-09-02 Kalowski Lee Chief Financial Officer Sale −2,158 $12.96 $28K 45,621
2015-04-16 Kalowski Lee Chief Financial Officer Sale −4,567 $13.00 $59K 47,779
2015-04-02 Kalowski Lee Chief Financial Officer Sale −2,258 $11.45 $26K 52,346
2014-09-17 Kalowski Lee Chief Financial Officer Grant or award +54,604 54,604
2014-09-17 Kalowski Lee Chief Financial Officer Grant or award · Stock Option (right to buy) +218,417 218,417

Page 1 of 1 · 7 trades